DegarelixHormone TherapySafety Rating 8/10
Primary research areaAdvanced prostate cancer
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range240 mg loading dose SC, then 80 mg monthly
AdministrationSubcutaneous injection
Safety8/10 · FDA-approved (Firmagon)
NCAA D1Banned
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Degarelix
Mechanism of action
GnRH receptor antagonist; immediate testosterone castration without initial testosterone flare
Safety profile
Injection site reactions, hot flashes, weight gain · Approved for prostate cancer; injection site reactions common but manageable
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Degarelix below your target.
Related pages